Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.
Wang W, Xiong Y, Hu X, Lu F, Qin T, Zhang L, Guo E, Yang B, Fu Y, Hu D, Fan J, Qin X, Liu C, Xiao R, Chen G, Li Z, Sun C.
Wang W, et al. Among authors: fu y.
Acta Biomater. 2023 Feb;157:428-441. doi: 10.1016/j.actbio.2022.12.021. Epub 2022 Dec 19.
Acta Biomater. 2023.
PMID: 36549633
Free article.